Miv Therapeutics, Inc. (IVT) Tops Q4 EPS by 8c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q4 EPS of $0.13, $0.08 better than the analyst estimate of $0.05.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• BeWhere acquires SecureQuip Systems for $789,000 in cash
• RBC Capital on Veeva Systems (VEEV) Amid After Hours Selloff on Earnings: 'we are surprised to see shares trade down'